Tesamorelin vs CJC-1295: GH Secretagogue Research Comparison
By UK Peptide Lab Research Team•17 May 2026•7 min read
Growth Hormone Secretagogue Class
Growth hormone-releasing hormone (GHRH) is a 44-amino-acid hypothalamic peptide that stimulates the anterior pituitary to release growth hormone (GH). Both Tesamorelin and CJC-1295 are synthetic GHRH analogues, but they differ in molecular modifications, pharmacokinetics, and pulsatility profile. Researchers studying the GH axis often compare them when designing in-vitro and animal protocols examining endogenous GH release patterns versus sustained elevation.
Tesamorelin: Stabilised Full-Length GHRH Analogue
Tesamorelin is a 44-amino-acid GHRH analogue with a trans-3-hexenoic acid moiety attached to the N-terminus. This modification protects the peptide from enzymatic degradation by dipeptidyl peptidase-4 (DPP-4), which would otherwise cleave native GHRH within minutes of administration. The result is a peptide with the full native GHRH sequence and signalling profile, but with substantially extended in-vivo stability. Tesamorelin preserves the natural pulsatile pattern of GH secretion, meaning research models show GH peaks and troughs consistent with physiological release rhythms.
CJC-1295: Modified GHRH(1-29) with Optional DAC
CJC-1295 is a 30-amino-acid truncated GHRH(1-29) analogue with four amino acid substitutions that improve resistance to enzymatic degradation and increase receptor binding affinity. The compound exists in two research forms: CJC-1295 without DAC (also called Mod GRF 1-29) and CJC-1295 with DAC (Drug Affinity Complex), the latter adding a maleimidopropionic acid linker that binds to circulating albumin. Without DAC, CJC-1295 has a half-life of around 30 minutes and preserves pulsatile GH release. With DAC, the half-life extends to approximately 8 days, producing sustained rather than pulsatile GH elevation.
Pulsatile vs Sustained Release Profiles
The distinction between pulsatile and sustained GH elevation is mechanistically important. Native GH secretion in mammals follows a pulsatile pattern with peaks every 3-5 hours and troughs near zero. Pulsatile signalling activates STAT5b-dependent gene expression in target tissues such as the liver, driving IGF-1 production in characteristic patterns. Sustained GH elevation, as produced by CJC-1295 with DAC, generates a flatter signalling curve that activates different downstream transcriptional pathways. Tesamorelin and non-DAC CJC-1295 preserve pulsatility. DAC-modified CJC-1295 abolishes it. Research model selection between the two often depends on whether physiological pulsatility is required.
Research Applications
Tesamorelin has been extensively studied in HIV-associated lipodystrophy research, where visceral adipose tissue reduction was demonstrated in clinical trials published by Falutz and colleagues in the New England Journal of Medicine in 2007. CJC-1295 with and without DAC has been used in research examining GH/IGF-1 axis kinetics, body composition models, and combination protocols with GH-releasing peptide analogues such as Ipamorelin. The combination of a GHRH analogue with a ghrelin-mimetic GHRP is a frequently studied protocol in pituitary signalling research.
Laboratory Handling
Both peptides are supplied as lyophilised powder. Store at -20°C prior to reconstitution. Reconstitute with bacteriostatic water by injecting slowly down the side of the vial and gently swirling. Store reconstituted solutions at 2-8°C and use within 4 weeks. Tesamorelin and CJC-1295 are both sensitive to repeated freeze-thaw cycles which compromise peptide integrity.
Sourcing in the UK
UK Peptide Lab supplies research-grade Tesamorelin 5mg, CJC-1295 5mg, and CJC-1295 with DAC 5mg with full third-party Certificate of Analysis published on every product page. Same-day UK dispatch on orders before 2pm GMT, free Royal Mail Tracked shipping over £45. For in-vitro laboratory research use only.
Related Products
Disclaimer: This article is for research and educational purposes only. All information provided is not intended as medical advice. UK Peptide Lab products are not for human consumption and are sold strictly for laboratory research use only.